Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis

NCT07707141 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HPP737 6mg and placebo
DRUG: HPP737 10mg and placebo
DRUG: HPP737 20mg
DRUG: HPP737 placebo

Sponsor

Newsoara Biopharma Co., Ltd.